These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1355148)

  • 41. Reduction of left ventricular hypertrophy after longterm antihypertensive treatment with doxazosin.
    Agabiti-Rosei E; Muiesan ML; Rizzoni D; Zulli R; Calebich S; Beschi M; Castellano M; Muiesan G
    J Hum Hypertens; 1992 Feb; 6(1):9-15. PubMed ID: 1349920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of an increase in time vs. frequency on cardiovascular parameters in chronic hemodialysis patients.
    Weinreich T; De los Ríos T; Gauly A; Passlick-Deetjen J
    Clin Nephrol; 2006 Dec; 66(6):433-9. PubMed ID: 17176915
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The influence of increasing dialysis treatment time and reducing dry weight on blood pressure control in hemodialysis patients: a prospective study.
    Luik AJ; v d Sande FM; Weideman P; Cheriex E; Kooman JP; Leunissen KM
    Am J Nephrol; 2001; 21(6):471-8. PubMed ID: 11799264
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autonomic blockade and the Valsalva maneuver in patients on maintenance hemodialysis: a hemodynamic study.
    McGrath BP; Tiller DJ; Bune A; Chalmers JP; Korner PI; Uther JB
    Kidney Int; 1977 Oct; 12(4):294-302. PubMed ID: 599840
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The cardiovascular effects of morphine. The peripheral capacitance and resistance vessels in human subjects.
    Zelis R; Mansour EJ; Capone RJ; Mason DT
    J Clin Invest; 1974 Dec; 54(6):1247-58. PubMed ID: 4612057
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacotherapeutic stature of doxazosin and its role in coronary risk reduction.
    Taylor SH
    Am Heart J; 1988 Dec; 116(6 Pt 2):1735-47. PubMed ID: 2904744
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: a comparative study.
    Fagugli RM; Pasini P; Pasticci F; Ciao G; Cicconi B; Buoncristiani U
    J Nephrol; 2006; 19(1):77-83. PubMed ID: 16523430
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Doxazosin, an alpha 1-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in man.
    Vincent J; Elliott HL; Meredith PA; Reid JL
    Br J Clin Pharmacol; 1983 Jun; 15(6):719-25. PubMed ID: 6135439
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypertension and peripheral arterial disease: a plethysmographic study.
    Milio G; Cospite V; Cospite M
    Angiology; 1997 Mar; 48(3):241-5. PubMed ID: 9071200
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical pharmacotherapeutics of doxazosin.
    Taylor SH
    Am J Med; 1989 Aug; 87(2A):2S-11S. PubMed ID: 2569822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intensive Hemodialysis, Blood Pressure, and Antihypertensive Medication Use.
    Bakris GL; Burkart JM; Weinhandl ED; McCullough PA; Kraus MA
    Am J Kidney Dis; 2016 Nov; 68(5S1):S15-S23. PubMed ID: 27772639
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of autonomic pathology in uremia on the blood pressure during hemodialysis].
    Koteva A; Krivoshiev S; Zlatarska S; Kambova L; Georgiev M
    Vutr Boles; 1989; 28(3):82-5. PubMed ID: 2773466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of the venodilated state on sympathetic-induced venoconstriction in normal subjects.
    Sumner A; Zelis R; Bennett M; Gascho JA
    Am J Cardiol; 1989 Apr; 63(13):973-6. PubMed ID: 2494876
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased venous distensibility in essential hypertension: lack of systemic hemodynamic correlates.
    Simon G; Franciosa JA; Cohn JN
    Angiology; 1979 Mar; 30(3):147-59. PubMed ID: 373515
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Computerized venous strain-gauge plethysmography is a reliable method for measuring venous function.
    Rosfors S; Persson LM; Blomgren L
    Eur J Vasc Endovasc Surg; 2014 Jan; 47(1):81-6. PubMed ID: 24262322
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Patients on chronic hemodialysis. Hemodynamic study at rest and during exercise before dialysis, in hypertensive and normotensive patients (author's transl)].
    Dongradi G; Kahn JC; Rocha P; Ben Fahrat M; Fendler JP
    Nouv Presse Med; 1978 Oct; 7(36):3207-11. PubMed ID: 733484
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduced venous responsiveness to endothelin-1 but not noradrenaline in hypertensive chronic renal failure.
    Hand MF; Haynes WG; Webb DJ
    Nephrol Dial Transplant; 2001 Feb; 16(2):295-301. PubMed ID: 11158403
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Arterial baroreflex sensitivity, plasma catecholamines, and pressor responsiveness in essential hypertension.
    Goldstein DS
    Circulation; 1983 Aug; 68(2):234-40. PubMed ID: 6407776
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ultrasound assessment of popliteal vein compliance during a short deflation protocol.
    Young CN; Prasad RY; Fullenkamp AM; Stillbower ME; Farquhar WB; Edwards DG
    J Appl Physiol (1985); 2008 May; 104(5):1374-80. PubMed ID: 18309095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pooling in chronic orthostatic intolerance: arterial vasoconstrictive but not venous compliance defects.
    Stewart JM
    Circulation; 2002 May; 105(19):2274-81. PubMed ID: 12010910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.